Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NMT2 | O60551 | 1/20 | 0.45 |
| ▸ | NMT1 | P30419 | 1/20 | 0.45 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.39 |
| ▸ | CPB2 | Q96IY4 | 2/20 | 0.38 |
| ▸ | CTSC | P53634 | 1/20 | 0.38 |
| ▸ | FURIN | P09958 | 2/20 | 0.38 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL379078 | 1.00 | NMT2 (0.45) | NMT2NMT1FOLH1CPB2CTSC | |
| SCHEMBL31027962 | 0.94 | NMT2 (0.43) | NMT2NMT1CPB2FURIN | |
| SCHEMBL30782953 | 0.94 | NMT1 (0.49) | NMT2NMT1FOLH1CPB2CTSC | |
| SCHEMBL30956312 | 0.91 | FOLH1 (0.47) | FOLH1CPB2CTSCSLC15A2 | |
| SCHEMBL827833 | 0.91 | NMT2 (0.45) | NMT2NMT1FOLH1CPB2FURIN | |
| SCHEMBL28382531 | 0.91 | NMT2 (0.45) | NMT2NMT1FOLH1CPB2FURIN | |
| SCHEMBL28382528 | 0.91 | NMT2 (0.45) | NMT2NMT1FOLH1CPB2FURIN | |
| SCHEMBL827832 | 0.91 | NMT2 (0.45) | NMT2NMT1FOLH1CPB2FURIN | |
| SCHEMBL29364543 | 0.89 | NMT1 (0.47) | NMT2NMT1CPB2 | |
| SCHEMBL29351142 | 0.89 | NMT1 (0.49) | NMT2NMT1FOLH1CPB2SLC15A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1618125-A4 | VITAMIN C DERIVATIVES WITH PEPTIDE, PREPARATION METHOD THEREOF AND COMPOSITION COMPRISING THE SAME | PEPTRON CO LTD (KR) | 2008-03-26 | — | — | EP | claimed |
| EP-1618125-A1 | VITAMIN C DERIVATIVES WITH PEPTIDE, PREPARATION METHOD THEREOF AND COMPOSITION COMPRISING THE SAME | Petron Co., Ltd. (KR) | 2006-01-25 | — | — | EP | claimed |
| WO-2004096837-A1 | VITAMIN C DERIVATIVES WITH PEPTIDE, PREPARATION METHOD THEREOF AND COMPOSITION COMPRISING THE SAME | PEPTRON CO., LTD (KR) | 2004-11-11 | — | — | WO | claimed |
| CN-120136974-A | Cyclopentapeptide-4, preparation method thereof and polypeptide cosmetic | 陕西未来多肽生物科技有限公司 | 2025-06-13 | — | — | CN | disclosed |
| EP-4436538-A1 | COSMETIC OR PHARMACEUTICAL PREPARATION FOR SKIN CARE AND IMPROVING SKIN CONDITION | Merryvital AG (CH) | 2024-10-02 | — | — | EP | disclosed |
| CN-117940113-A | Injectable composition comprising hyaluronic acid and amino acid | 专业皮肤护理有限公司 | 2024-04-26 | — | — | CN | disclosed |
| US-20240041740-A1 | SKIN PEEL COMPOSITIONS | GLO PHARMA INC (US) | 2024-02-08 | — | — | US | disclosed |
| US-20230270635-A1 | METHODS AND COMPOSITIONS FOR COSMETIC APPLICATIONS | GLO PHARMA INC (US) | 2023-08-31 | — | — | US | disclosed |
| WO-2023094852-A1 | COSMETIC OR PHARMACEUTICAL PREPARATION FOR SKIN CARE AND IMPROVING SKIN CONDITION | MERRYVITAL AG (CH) | 2023-06-01 | — | — | WO | disclosed |
| EP-3938055-A1 | AN ANTIMICROBIAL MIXTURE | Symrise AG (DE) | 2022-01-19 | — | — | EP | disclosed |
| WO-2020182318-A1 | AN ANTIMICROBIAL MIXTURE | SYMRISE AG (DE) | 2020-09-17 | — | — | WO | disclosed |
| EP-2593077-A2 | CYCLOHEXYL CARBAMATE COMPOUNDS AS SKIN AND/OR HAIR LIGHTENING ACTIVES | Symrise AG (DE) | 2013-05-22 | — | — | EP | disclosed |
| WO-2012091743-A1 | OLEANOYL PEPTIDE COMPOSITION AND A METHOD OF TREATING SKIN AGING | SAMI LABS LIMITED (IN) | 2012-07-05 | — | — | WO | disclosed |
| EP-2408801-A1 | PEPTIDES USED IN THE TREATMENT AND/OR CARE OF THE SKIN, MUCOUS MEMBRANES AND/OR SCALP AND THEIR USE IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS | Lipotec, S.A. (ES) | 2012-01-25 | — | — | EP | disclosed |
| WO-2010122178-A2 | CYCLOHEXYL CARBAMATE COMPOUNDS AS SKIN AND/OR HAIR LIGHTENING ACTIVES | SYMRISE GMBH & CO. KG (DE) | 2010-10-28 | — | — | WO | disclosed |
| WO-2010097480-A2 | MENTHYL CARBAMATE COMPOUNDS AS SKIN AND/OR HAIR LIGHTENING ACTIVES | SYMRISE GMBH & CO. KG (DE) | 2010-09-02 | — | — | WO | disclosed |
| WO-2010091893-A1 | PEPTIDES USED IN THE TREATMENT AND/OR CARE OF THE SKIN, MUCOUS MEMBRANES AND/OR SCALP AND THEIR USE IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS | LIPOTEC, S.A. (ES) | 2010-08-19 | — | — | WO | disclosed |
| EP-1618125-A4 | VITAMIN C DERIVATIVES WITH PEPTIDE, PREPARATION METHOD THEREOF AND COMPOSITION COMPRISING THE SAME | PEPTRON CO LTD (KR) | 2008-03-26 | — | — | EP | disclosed |
| EP-1618125-A1 | VITAMIN C DERIVATIVES WITH PEPTIDE, PREPARATION METHOD THEREOF AND COMPOSITION COMPRISING THE SAME | Petron Co., Ltd. (KR) | 2006-01-25 | — | — | EP | disclosed |
| WO-2004096837-A1 | VITAMIN C DERIVATIVES WITH PEPTIDE, PREPARATION METHOD THEREOF AND COMPOSITION COMPRISING THE SAME | PEPTRON CO., LTD (KR) | 2004-11-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230270635-A1 | METHODS AND COMPOSITIONS FOR COSMETIC APPLICATIONS | CUTA, GLA, LIPA | NMT2 1989/4885NMT1 2462/4885FOLH1 1417/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.